journal of men's health
Volume 5, Issue 4 , Pages 314-317 , December 2008

The influence of ethnicity on Gleason score

  • Scott E. Woods, MD, MPH, MEd, FAAFP

      Affiliations

    • Bethesda Family Medicine Residency Program, 4411 Montgomery Road, Cincinnati, OH, 45212, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Jennifer Messer, MD

      Affiliations

    • Bethesda Family Medicine Residency Program, 4411 Montgomery Road, Cincinnati, OH, 45212, USA
    • ,
  • Amy Engel, MA

      Affiliations

    • The E. Kenneth Hatton, M.D. Institute for Research and Education, Cincinnati, Ohio, USA

Received 23 April 2008 ,Accepted 22 September 2008.

References 

  1. American Cancer Society. Cancer Facts and Figures 2007. Available at: http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts__Figures_2007.asp [Accessed August 16, 2007].
  2. American Cancer Society. Cancer Facts and Figures for African Americans 2007-2008. Available at: http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts__Figures_for_African_Americans_2007-2008.asp [Accessed August 16, 2007].
  3. Fowler JE, Bigler SA, Farabaugh PB. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/ml. Cancer. 2001;94:1661–1667
  4. Mettlin CJ, Murphy GP, McGionnis LS, Menck HR. The National Cancer Data Base report on prostate cancer. Cancer. 1995;76:1104–1112
  5. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966;50:125–128
  6. Gleason DF. The veterans administrative cooperative urologic research group: histological grading and clinical staging of prostatic carcinoma. In:  Tannenbaum M editors. Urologic Pathology: The Prostate.. Philadelphia: Lea & Febiger; 1977;p. 171–198
  7. Sogani PC, Israel A, Lieberman PH, Lesser ML, Whitmore WF. Gleason grading of prostate cancer: a predictor of survival. Urology. 1985;25:223–227
  8. Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens. J Urol. 1998;160:437–442
  9. Fowler JE, Bigler SA. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma. Cancer. 1999;86:836–841
  10. Fowler JE, Bigler SA. Racial differences in prostate carcinogenesis: histologic and clinical observations. Urol Clin N Am. 2002;29:183–191
  11. Berger AD, Satagopan J, Lee P, Taneja SS, Osman I. Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990 s and 2000 s. Urology. 2006;67:120–124
  12. Robbins AS, Yin D, Parikh-Patel A. Differences in prognostic factors and survival among white men and black men with prostate cancer, California, 1995-2004. Am J Epidemiol. 2007;166:71–78
  13. Bryant RJ, Hamdy FC. Screening for prostate cancer: an update. Eur Urol. 2007;120:743–745
  14. American Academy of Family Practitioners. Available at: www.aafp.org/online/etc/medialib/aafp_org/documents/clinical/clin_recs/cps.PAR.001.File.tmp/August2006.cps.pdf [Accessed September 20, 2007].
  15. U.S. Preventative Health Services Task Force. Available at: www.ahrq.gov/clinic/uspstf/uspsprca.htm [Accessed September 20, 2007].

PII: S1875-6867(08)00196-6

doi: 10.1016/j.jomh.2008.09.003

journal of men's health
Volume 5, Issue 4 , Pages 314-317 , December 2008

Article Tools